@article{GlaserSchultheisMolletal.2015,
  author    = {Glaser, Jan and Schultheis, Martina and Moll, Heidrun and Hazra, Banasri and Holzgrabe, Ulrike},
  title     = {Antileishmanial and Cytotoxic Compounds from Valeriana wallichii and Identification of a Novel Nepetolactone Derivative},
  series = {Molecules},
  volume    = {20},
  journal   = {Molecules},
  number    = {4},
  doi       = {10.3390/molecules20045740},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-125320},
  pages     = {5740-5753},
  year      = {2015},
  abstract  = {The chloroform extract of Valeriana wallichii (V. wallichii) rhizomes was investigated to elucidate the structures responsible for reported antileishmanial activity. Besides bornyl caffeate (1, already been reported by us previously), bioassay-guided fractionation resulted in two additional cinnamic acid derivatives 2-3 with moderate leishmanicidal activity. The structure of a novel nepetolactone derivative 4 having a cinnamic acid moiety was elucidated by means of spectral analysis. To the best of our knowledge villoside aglycone (5) was isolated from this plant for the first time. The bioassay-guided fractionation yielded two new (compounds 6-7) and two known valtrates (compounds 8-9) with leishmanicidal potential against Leishmania major (L. major) promastigotes. In addition, β-bisabolol (10), α-kessyl alcohol (11), valeranone (12), bornyl isovalerate (13) and linarin-2-O-methylbutyrate (14) were identified. This is the first report on the isolation of 4'-demethylpodophyllotoxin (15), podophyllotoxin (16) and pinoresinol (17) in V. wallichii. In total thirteen known and four new compounds were identified from the extract and their cytotoxic and antileishmanial properties were evaluated.},
  language  = {en}
}
@phdthesis{Glaser2015,
  author    = {Glaser, Jan},
  title     = {Antileishmanial compounds from Nature - Elucidation of the active principles of an extract from Valeriana wallichii rhizomes},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-129140},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {This study is dealing with the bioactivity-guided fractionation of a chloroform extract from pulverized rhizomes of Valeriana wallichii with focus on isolation and structure elucidation of the antileishmanial active principles.},
  subject      = {Leishmaniose},
  language  = {en}
}
@phdthesis{Kessler2015,
  author    = {Keßler, Martina},
  title     = {Biodegradable solvent cast films and solution electrospun meshes for the prevention of postsurgical adhesions},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-129358},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {Intraperitoneal adhesions are fibrous bands that connect tissues in the peritoneal cavity that are usually separated. These adhesions form as a consequence of trauma, inflammation or surgical interventions and often result in severe consequences such as chronic pain, small bowel obstructions or female infertility. The aim of this thesis was to develop a synthetic barrier device for adhesion prevention made of modified poly(lactide) [PLA]. Solid PLA films (SurgiWrap®) are already successfully in clinical use due to the good biocompatibility and the biodegradability of the material resulting in non-toxic degradation products since lactic acid is naturally part of the metabolic circles of the human body. Considering the brittleness and stiffness of the films, the long degradation time of several months as well as the need for suturing, there is potential for optimization. Through a copolymerization with the hydrophilic poly(ethylene glycol) [PEG], a reduction of the degradation time was intendend. Moreover, the copolymerization should also lead to an improvement of the mechanical properties of the films since PEG acts as plasticizer for PLA. Linear PLA-PEG-PLA triblock copolymers as well as star-shaped PEG-PLA copolymers were synthesized via standard ring opening polymerization to tailor the barrier properties. Besides solid films, solution electrospun meshes from PLA and the synthesized PEG-PLA copolymers were investigated for a potential application as well. Since suturing of a barrier additionally induces adhesion formation, alginate coated membranes were prepared in order to achieve self-adhesiveness. With the intention to reduce infections and consequently inflammation, electrospun meshes and solvent cast films were loaded with the antibacterial drug triclosan and drug release as well as antibacterial efficacy was investigated. Mechanical tests confirmed that through the variation of the PEG content and branching the mechanical properties can be tailored and are in good accordance with the glass transition temperatures [Tg] of the polymers. Consequently, potentially adequate mechanical properties for surgical handling as well as for the performance within the patient's body were successfully achieved. Degradation studies revealed that the degradation time was significantly shorter for PEG-PLA membranes than for PLA films and with an appropriate PEG content could be adjusted to the intended time frame. Cell adhesion and viability tests confirmed the non-toxicity of the clinically used PLA films as well as of PEG-PLA films and meshes. With a bioadhesion test the benefit of an alginate coated side towards the pure PLA film concerning self-adhesiveness was successfully demonstrated. Moreover, optical evaluations and a T-peel test of different alginate coated PLA films showed that the cohesion between the chemically different layers was distinctly enhanced by the use of an appropriate PEG-PLA mesh as intermediate cohesion promoting layer. In in vitro release studies with triclosan loaded films a higher release was determined for PEG-PLA than for PLA films. In agar diffusion tests a higher and longer inhibition of staphylococcus aureus growth was observed confirming the release results. Moreover, drug loaded meshes (especially drug loaded after electrospinning) showed enhanced and elongated bacterial inhibition in comparison to films.},
  subject      = {Polymere},
  language  = {en}
}
@phdthesis{Vollmers2015,
  author    = {Vollmers, Frederic},
  title     = {Charakterisierung der pulmonalen Pharmakokinetik von Salmeterol und Insulin-like Growth Factor-1},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-118632},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {F{\"u}r inhalativ applizierte Arzneimittel spielt das Ausmaß der pulmonalen Absorption eine entscheidende Rolle. F{\"u}r Substanzen, die lokal in der Lunge wirken sollen, sind f{\"u}r eine gute Wirksamkeit hohe lokale Wirkstoffkonzentrationen, und f{\"u}r eine geringe Nebenwirkungsrate niedrige systemische Plasmaspiegel wichtig. Sollen allerdings Substanzen das Lungenepithel {\"u}berwinden und im systemischen Kreislauf wirken, ist eine hohe systemische Verf{\"u}gbarkeit f{\"u}r eine gute Wirkung gew{\"u}nscht. Das Ziel dieser Studie war es mit in vitro und ex vivo Methoden das Absorptions- und Permeationsverhalten von pulmonal applizierten Substanzen zu studieren. Der Transportmechanismus {\"u}ber das Lungenepithel des langwirksamen ß2-Agonisten Salmeterol wurde mithilfe des humanen ex vivo Lungenperfusionsmodells untersucht. Die Anwendung von L-Carnitin als Hemmstoff von organischen Kationen/Carnitin Transportern (OCT/N) bewirkte eine Verringerung der pulmonalen Absorption von Salmeterol von ca. 90 \%, was auf eine Beteiligung von Transportern, m{\"o}glicherweise des OCTN2 oder OTCN1, f{\"u}r den Transport von Salmeterol {\"u}ber das Lungenepithel hindeutete. Es wurde somit zum ersten Mal erfolgreich gezeigt, dass Salmeterol wahrscheinlich als Substrat der Transportproteine fungiert und der {\"U}bertritt {\"u}ber das Lungenepithel von organischen Kationen/Carnitin Transportern abh{\"a}ngig ist. Bisher wurde eine Interaktion von Salmeterol mit den OCT/N nur in in vitro Versuchen studiert und Salmeterol wurde nur als Hemmstoff und nicht als Substrat untersucht. Die Beteiligung eines Transporters f{\"u}r die pulmonale Absorption von Salmeterol steht außerdem im Einklang mit Untersuchungen {\"u}ber weitere ß2-Agonisten wie das kurzwirksame Salbutamol und das langwirksame GW597901. Somit scheinen sowohl lipophile als auch hydrophile ß2-Agonisten Substrate f{\"u}r die OCT/N zu sein. Die F{\"a}higkeit von IGF-1, nach pulmonaler Applikation in den systemischen Kreislauf zu gelangen, wurde in der vorliegenden Studie mit Hilfe des Lungenperfusionsmodells untersucht. Das IGF-1 wurde gebunden an Trehalose oder an Fibroin als Pulver verabreicht. Die Trehalose sollte eine schnelle Abgabe des IGF 1 bewirken, und das Fibroin sollte zum einen ein Tr{\"a}germaterial mit sch{\"u}tzenden Eigenschaften f{\"u}r das IGF 1 darstellen, und zum anderen sollte eine m{\"o}gliche verz{\"o}gerte Freisetzung von IGF-1 aus Fibroin in einem ex vivo Modell untersucht werden, die in vorausgegangenen in vitro Versuchen {\"u}ber 3 h lang vorhanden war. Das Peptid wurde nach der Applikation sowohl der Trehalosepartikel als auch der Fibroinpartikel pulmonal absorbiert und folgte einer linearen Verteilungskinetik. Dieses lineare Absorptionsverhalten des IGF-1 war vergleichbar mit der Kinetik von inhalativem Insulin, die in in vivo Studien beobachtet wurde. Somit konnte gezeigt werden, dass das IGF-1 nach pulmonaler Applikation systemisch verf{\"u}gbar sein k{\"o}nnte und eine vergleichbare pulmonale Pharmakokinetik wie das strukturell {\"a}hnliche Insulin besitzt. Außerdem unterschied sich das Absorptionsverhalten von IGF-1, gebunden an Trehalose, nicht signifikant von dem von IGF-1/Fibroin, was im Gegensatz zu in vitro Untersuchungen stand, in denen das IGF-1 verz{\"o}gert aus Fibroin freigesetzt wurde. Somit wirkte sich die kontrollierte Abgabe in vitro nicht auf die Verteilungskinetik ex vivo aus. Daraus ergibt sich, dass sowohl Trehalose als auch Fibroin als Tr{\"a}germaterial f{\"u}r IGF-1 zur pulmonalen Applikation geeignet w{\"a}ren, und dass IGF-1, gebunden an Fibroin eine Formulierung w{\"a}re, die zum einen das IGF 1 sch{\"u}tzen kann und die zum anderen eine gleiche pulmonale Kinetik wie IGF 1, gebunden an schnell aufl{\"o}sende Tr{\"a}gersubstanzen, besitzt. Außerdem wurde dadurch die Wichtigkeit betont, die Pharmakokinetik von pulmonal verabreichten Substanzen am intakten Organ mit erhaltener Komplexit{\"a}t und Funktionalit{\"a}t zu untersuchen, und dass das Lungenperfusionsmodell hierf{\"u}r eine geeignete Methode darstellt. Dar{\"u}ber hinaus wurde belegt, dass mithilfe des Lungenperfusionsmodells erfolgreich pharmakokinetische Daten f{\"u}r nieder- und h{\"o}hermolekulare Substanzen gesammelt werden k{\"o}nnen, die als Aerosol oder als Pulver appliziert werden. Auch in den in der vorliegenden Arbeit durchgef{\"u}hrten in vitro Permeationsversuchen, die mit der Bronchialepithelzelllinie Calu-3 durchgef{\"u}hrt wurden, zeigte IGF-1 vergleichbare lineare Permeationseigenschaften wie das Insulin, mit einem apparenten Permeationskoeffizienten von 1,49 * 10-8 cm/sec f{\"u}r IGF-1 und 2,11 * 10-8 cm/sec f{\"u}r Insulin. Das IGF 1 schien durch die Calu-3 Zellen sowohl parazellul{\"a}r als auch transzytotisch zu permeieren, wie es f{\"u}r Makromolek{\"u}le generell vermutet wird. Durch die Verwendung von Hemmstoffen der Transzytose bzw. bestimmter endozytotischer Mechanismen in den Permeationsstudien konnte gezeigt werden, dass, wie bereits genannt, der Transport durch die Zellen eine wichtige Rolle f{\"u}r den {\"U}bertritt von IGF-1 {\"u}ber Calu-3 Zellmonolayer spielte. Die Studien ergaben außerdem, dass die zellul{\"a}re Aufnahme des IGF-1 unabh{\"a}ngig von Clathrin und abh{\"a}ngig von Dynamin war. Der Einsatz einer humanen bronchioalveol{\"a}ren Lavage in den Permeationsversuchen bewirkte zum einen eine Erh{\"o}hung des Transportes von IGF 1 durch die Calu-3 Zellen, und zum anderen war die zellul{\"a}re Aufnahme in diesem Fall unabh{\"a}ngig von Dynamin und unterschied sich somit von den vorherigen Untersuchungen, in denen keine Lavage eingesetzt wurde. Das bedeutet, dass Faktoren in einer bronchioalveolaren Lavage enthalten waren, die sowohl das Ausmaß der Permeation als auch den Mechanismus der zellul{\"a}ren Aufnahme von IGF-1 in Calu-3 Zellen beeinflussten. Zusammenfassend konnten in der vorliegenden Arbeit erfolgreich weitere Hinweise f{\"u}r die Beteiligung von Transportern an der pulmonalen Absorption von ß2-Agonisten mithilfe des ex vivo Lungenperfusionsmodells gefunden werden, was somit eine wertvolle Erg{\"a}nzung zu bisher vorhanden in vitro Studien darstellt. Daneben wurde zum ersten Mal gezeigt, dass das IGF-1 nach Applikation in die Lunge pulmonal absorbiert werden k{\"o}nnte. Das belegt den Nutzen der Lunge als Eintrittsort in den systemischen Kreislauf, was vor allem f{\"u}r peptidische Arzneistoffe von Bedeutung ist.},
  subject      = {Lunge},
  language  = {de}
}
@phdthesis{Merget2015,
  author    = {Merget, Benjamin},
  title     = {Computational methods for assessing drug-target residence times in bacterial enoyl-ACP reductases and predicting small-molecule permeability for the \(Mycobacterium\) \(tuberculosis\) cell wall},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-127386},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {\textbf{Molecular Determinants of Drug-Target Residence Times of Bacterial Enoyl-ACP Reductases.} Whereas optimization processes of early drug discovery campaigns are often affinity-driven, the drug-target residence time \$t_R\$ should also be considered due to an often strong correlation with \textit{in vivo} efficacy of compounds. However, rational optimization of \$t_R\$ is not straightforward and generally hampered by the lack of structural information about the transition states of ligand association and dissociation. The enoyl-ACP reductase FabI of the fatty acid synthesis (FAS) type II is an important drug-target in antibiotic research. InhA is the FabI enzyme of \textit{Mycobacterium tuberculosis}, which is known to be inhibited by various compound classes. Slow-onset inhibition of InhA is assumed to be associated with the ordering of the most flexible protein region, the substrate binding loop (SBL). Diphenylethers are one class of InhA inhibitors that can promote such SBL ordering, resulting in long drug-target residence times. Although these inhibitors are energetically and kinetically well characterized, it is still unclear how the structural features of a ligand affect \$t_R\$. Using classical molecular dynamics (MD) simulations, recurring conformational families of InhA protein-ligand complexes were detected and structural determinants of drug-target residence time of diphenyl\-ethers with different kinetic profiles were described. This information was used to deduce guidelines for efficacy improvement of InhA inhibitors, including 5'-substitution on the diphenylether B-ring. The validity of this suggestion was then analyzed by means of MD simulations. Moreover, Steered MD (SMD) simulations were employed to analyze ligand dissociation of diphenylethers from the FabI enzyme of \textit{Staphylococcus aureus}. This approach resulted in a very accurate and quantitative linear regression model of the experimental \$ln(t_R)\$ of these inhibitors as a function of the calculated maximum free energy change of induced ligand extraction. This model can be used to predict the residence times of new potential inhibitors from crystal structures or valid docking poses. Since correct structural characterization of the intermediate enzyme-inhibitor state (EI) and the final state (EI*) of two-step slow-onset inhibition is crucial for rational residence time optimization, the current view of the EI and EI* states of InhA was revisited by means of crystal structure analysis, MD and SMD simulations. Overall, the analyses affirmed that the EI* state is a conformation resembling the 2X23 crystal structure (with slow-onset inhibitor \textbf{PT70}), whereas a twist of residues Ile202 and Val203 with a further opened helix \$\alpha 6\$ corresponds to the EI state. Furthermore, MD simulations emphasized the influence of close contacts to symmetry mates in the SBL region on SBL stability, underlined by the observation that an MD simulation of \textbf{PT155} chain A with chain B' of a symmetry mate in close proximity of the SBL region showed significantly more stable loops, than a simulation of the tetrameric assembly. Closing Part I, SMD simulations were employed which allow the delimitation of slow-onset InhA inhibitors from rapid reversible ligands. \textbf{Prediction of \textit{Mycobacterium tuberculosis} Cell Wall Permeability.} The cell wall of \textit{M. tuberculosis} hampers antimycobacterial drug design due to its unique composition, providing intrinsic antibiotic resistance against lipophilic and hydrophilic compounds. To assess the druggability space of this pathogen, a large-scale data mining endeavor was conducted, based on multivariate statistical analysis of differences in the physico-chemical composition of a normally distributed drug-like chemical space and a database of antimycobacterial--and thus very likely permeable--compounds. The approach resulted in the logistic regression model MycPermCheck, which is able to predict the permeability probability of small organic molecules based on their physico-chemical properties. Evaluation of MycPermCheck suggests a high predictive power. The model was implemented as a freely accessible online service and as a local stand-alone command-line version. Methodologies and findings from both parts of this thesis were combined to conduct a virtual screening for antimycobacterial substances. MycPermCheck was employed to screen the chemical permeability space of \textit{M. tuberculosis} from the entire ZINC12 drug-like database. After subsequent filtering steps regarding ADMET properties, InhA was chosen as an exemplary target. Docking to InhA led to a principal hit compound, which was further optimized. The quality of the interaction of selected derivatives with InhA was subsequently evaluated using MD and SMD simulations in terms of protein and ligand stability, as well as maximum free energy change of induced ligand egress. The results of the presented computational experiments suggest that compounds with an indole-3-acethydrazide scaffold might constitute a novel class of InhA inhibitors, worthwhile of further investigation.},
  subject      = {Computational chemistry},
  language  = {en}
}
@phdthesis{Mailaender2015,
  author    = {Mail{\"a}nder, Lisa},
  title     = {Darstellung neuer Borheterocyclen durch Umsetzung von Borolen mit 1,3-dipolaren Reagenzien},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-127147},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {Darstellung neuer Borheterocyclen durch Umsetzung von Borolen mit 1,3-dipolaren Reagenzien. Bei der Usetzung von Borolen mit Aziden, Diazoalkanen und Nitronen kam es zu Ringerweiterungsreaktionen und zur Bildung von neuen Borheterocyclen (z.B. 1,2-Azaborinine, 1,2-Azaborinin-substituierte Azofarbstoffe, Boracyclohexadiene, Oxazaborocine).},
  subject      = {Borole},
  language  = {de}
}
@phdthesis{Brand2015,
  author    = {Brand, Johannes},
  title     = {Darstellung und Untersuchung von niederkoordinierten Platinimino-, Platinoxo- und Platinalkylidenborylkomplexen},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-112306},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {Diese Dissertation handelt von der Darstellung, Charakterisierung und Reaktivit{\"a}tsuntersuchungen von neuartigen Platinalkylidenborylkomplexen und eines heteroleptischen Platiniminoborylkomplexes. Außerdem wurden Reaktivit{\"a}tsuntersuchungen an einem Platinoxoborylkomplex durchgef{\"u}hrt und die erhaltenen Produkte wurden genau untersucht und charakterisiert.},
  subject      = {Dreifachbindung},
  language  = {de}
}
@phdthesis{Becker2015,
  author    = {Becker, Johannes},
  title     = {Development and implementation of new simulation possibilities in the CAST program package},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-132032},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {The aim of the present work is the development and implementation of new simulation possibilities for the CAST program package. Development included, among other things, the partial parallelization of the already existing force fields, extension of the treatment of electrostatic interactions and implementation of molecular dynamics and free energy algorithms. The most time consuming part of force field calculations is the evaluation of the nonbonded interactions. The calculation of these interactions has been parallelized and it could be shown to yield a significant speed up for multi-core calculations compared to the serial execution on only one CPU. For both, simple energy/gradient as well as molecular dynamics simulations the computational time could be significantly reduced. To further increase the performance of calculations employing a cutoff radius, a linkedcell algorithm was implemented which is able to build up the non-bonded interaction list up to 7 times faster than the original algorithm. To provide access to dynamic properties based on the natural time evolution of a system, a molecular dynamics code has been implemented. The MD implementation features two integration schemes for the equations of motion which are able to generate stable trajectories. The basic MD algorithm as described in Section 1.2 leads to the sampling in the microcanonical (NVE) ensemble. The practical use of NVE simulations is limited though because it does not correspond to any experimentally realistic situation. More realistic simulation conditions are found in the isothermal (NVT) and isothermalisobaric (NPT) ensembles. To generate those ensembles, temperature and pressure control has been implemented. The temperature can be controlled in two ways: by direct velocity scaling and by a Nose-Hoover thermostat which produces a real canonical ensemble. The pressure coupling is realized by implementation of a Berendsen barostat. The pressure coupling can be used for isotropic or anisotropic box dimensions with the restriction that the angles of the box need to be 90� . A crucial simulation parameter in MD simulations is the length of the timestep. The timestep is usually in the rang of 1fs. Increasing the timestep beyond 1fs can lead to unstable trajectories since the fastest motion in the system, usually the H-X stretch vibration can not be sampled anymore. A way to allow for bigger timesteps is the use of a constraint algorithm which constrains the H-X bonds to the equilibrium distance. For this the RATTLE algorithm has been implemented in the CAST program. The velocity Verlet algorithm in combination with the RATTLE algorithm has been shown to yield stable trajectories for an arbitrary length of simulation time. In a first application the MD implementation is used in conjunction with the MOPAC interface for the investigation of PBI sidechains and their rigidity. The theoretical investigations show a nice agreement with experimentally obtained results. Based on the MD techniques two algorithms for the determination of free energy differences have been implemented. The umbrella sampling algorithm can be used to determine the free energy change along a reaction coordinate based on distances or dihedral angles. The implementation was tested on the stretching of a deca-L-alanine and the rotation barrier of butane in vacuum. The results are in nearly perfect agreement with literature values. For the FEP implementation calculations were performed for a zero-sum transformation of ethane in explicit solvent, the charging of a sodium ion in explicit solvent and the transformations of a tripeptide in explicit solvent. All results are in agreement with benchmark calculations of the NAMD program as well as literature values. The FEP formalism was then applied to determine the relative binding free energies between two inhibitors in an inhibitor-protein complex. Next to force fields, ab-initio methods can be used for simulations and global optimizations. Since the performance of such methods is usually significantly poorer than force field applications, the use for global optimizations is limited. Nevertheless significant progress has been made by porting these codes to GPUs. In order to make use of these developments a MPI interface has been implemented into CAST for communication with the DFT code TeraChem. The CAST/TeraChem combination has been tested on the \$H_2 O_{10}\$ cluster as well as the polypeptide met-Enkephalin. The pure ab-initio calculations showed a superior behavior compared to the standard procedure where the force field results are usually refined using quantum chemical methods.},
  subject      = {Molekulardynamik},
  language  = {en}
}
@phdthesis{Muelek2015,
  author    = {M{\"u}lek, Melanie},
  title     = {Distribution and metabolism of constituents and metabolites of a standardized maritime pine bark extract (Pycnogenol®) in human serum, blood cells and synovial fluid of patients with severe osteoarthritis},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-128085},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {Dietary polyphenols have been related to beneficial effects on humans' health. Pycnogenol®, a dietary polyphenol-rich food supplement complies with the monograph "Maritime pine extract" in the United States Pharmacopeia (USP) and has demonstrated effects in different diseases. Several human trials concerning knee osteoarthritis have shown significant improvement of the symptoms like reducing the pain and the stiffness of the joint(s) upon intake of Pycnogenol®. After oral intake of multiple doses of Pycnogenol® previously low concentrations in the nanomolar range of monomeric extract constituents have been found in human plasma as well as a bioactive metabolite, δ-(3,4-dihydroxy-phenyl)-γ-valerolactone (M1), which is formed by the human intestinal flora from the procyanidins' catechin units. It is not clear yet which compound(s) of the complex extract is (are) mainly responsible for the described clinical effects of Pycnogenol®. To gain deeper insights into the in vivo fate of the pine bark extract the distribution of its constitutents and metabolites was closer investigated in the present thesis. Initial in vitro experiments suggested a facilitated cellular uptake of M1 into human erythrocytes, possibly via GLUT-1 transporter. For elucidating further the in vitro and in vivo metabolism of M1 in human blood cells, a metabolomic approach was performed using UPLC-ESI-qTOF-MSE analysis, which revealed a comprehensive and rapid metabolism of M1 to a variety of biotransformation products in human blood cells. Predominant metabolites were found to be conjugates of glutathione (GSH) isomers, namely M1-S-GSH and M1-N-GSH. Further sulfur-containing biotransformation products of M1 were conjugates with oxidized glutathione (M1-GSSG) and cysteine (M1-CYS) and the sulfated derivative of M1 (M1-sulfated). Other in vitro biotransformation products constituted the open-chained ester form of M1 (M1-COOH), hydroxybenzoic acid and the methylated (M1-methylated), acetylated (M1-acetylated), hydroxylated (M1-hydroxylated) and ethylated (M1-ethylated) derivatives of M1. Indeed, six of these in vitro metabolites, respectively M1-COOH, M1-sulfated, hydroxybenzoic acid, M1-S-GSH, M1-methylated and M1-acetylated, were also identified in vivo in blood cells of human volunteers after ingestion of Pycnogenol®. Related reference material was synthesized for reliable confirmation of the metabolites M1-GSH, M1-GSSG, M1-CYS and M1-COOH. In the course of a randomized controlled clinical trial patients suffering from severe osteoarthritis ingested multiple doses of 200 mg/day Pycnogenol® for three weeks before they were scheduled for an elective knee replacement surgery. Various biological specimen, respectively blood cells, synovial fluid and serum samples, were to be analyzed to investigate the distribution and disposition of possibly bioactive constituents and metabolites. Therefore, highly sensitive methods were developed using liquid chromatography tandem mass spectrometry (LC-MS/MS)- technology because of the expected low concentrations of the analytes in the related matrices. Initially, for each matrix different sample preparation techniques (protein precipitation, liquid-liquid extraction, solid phase extraction and useful combinations thereof) were compared to achieve maximum detection sensitivity of the analytes that were of highest interest, namely M1, ferulic acid and taxifolin. By comparing 32 various sample clean-up procedures in human serum, the highest recovery of the metabolite M1 was achieved using a liquid-liquid extraction with ethyl acetate and tert-butyl methyl ether at a serum pH-value of 3.2. A similar extraction method was also chosen for analyte detection in human synovial fluid after comparing 31 different sample preparation techniques. Whole blood or blood cells are difficult to handle because of their high viscosity and strong coloration. The QuEChERS (quick, easy, cheap, effective, rugged and safe) approach which was originally developed for the food safety and thus for the determination of pesticide residues in fruits and vegetables yielded the highest total recovery rate of M1 in human blood cells when assessing 18 different sample clean-up techniques. By applying the QuEChERS method for the first time for the simultaneous and highly sensitive quantification of selected polyphenols in human blood cells it was demonstrated that this fast and inexpensive technique can be applied in clinical fields for cleaning-up highly complex and thus challenging biological matrices. All developed methods for the different biological specimen were optimized to achieve maximum sensitivity of the target analytes. The determined lower limits of quantification (LLOQs) were sufficient for the quantification of the study samples. The LLOQs ranged from 113 pg/mL for taxifolin to 48 ng/mL for caffeic acid in blood cells and from 80 pg/mL for taxifolin to 3 ng/mL for caffeic acid in synovial fluid. In human serum the LLOQs even ranged down to 35 pg/mL for taxifolin and up to 8 ng/mL for caffeic acid. All analytical methods were subjected to a full validation according to current EMA and FDA guidelines and fulfilled those criteria, showing excellent performance and reliability of the developed and optimized methods. Serum, blood cells and synovial fluid samples of the osteoarthritis patients were all processed with an enzymatic incubation with ß-glucuronidase/sulfatase to hydrolyse conjugates (phase-II-metabolism) prior the actual sample preparation. Additionally, serum samples of the osteoarthritis patients were prepared without enzymatic hydrolysis to determine the individual degree of conjugation with sulfate and glucuronic acid of the analytes. All determined concentrations in the patients' samples were in the lower ng/mL range. Notably, highest total concentrations of the polyphenols were not detected in serum, in which the degree of analyte conjugation with sulfate and glucuronic acid ranged from 54.29 ± 26.77\% for catechin to 98.34 ± 4.40\% for M1. The flavonoids catechin and taxifolin mainly partitioned into blood cells, whereas the metabolite M1, ferulic and caffeic acid primarily resided in the synovial fluid. The concentration of M1 in the blood cells was low, however, this could be explained by the previously observed extensive and rapid intracellular metabolism in vitro. This was now supported by the in vivo evidence in samples of patients who received Pycnogenol® in which the open-chained ester form of M1 (M1-COOH) as well as the glutathione conjugate of M1 (M1-GSH) were identified, indicating that M1 does not accumulate in its original form in vivo. Possibly, a variety of bioactive metabolites exist which might play an important role for the clinical effects of Pycnogenol®. Although the study participants were requested to avoid polyphenol-rich food and beverages within the last two days before the blood samplings this was obviously difficult for most of the patients. Hence, no statistically significantly difference was observed in the mean polyphenol concentrations in serum, blood cells and synovial fluid between the intervention and the control group. Nevertheless, it was possible to identify marker compounds for Pycnogenol® intake under real life conditions with occasional or regular consumption of polyphenol-rich foods and beverages. Thereby, ferulic acid was found in serum samples exclusively after intake of Pycnogenol®, confirming that ferulic acid is a suitable marker of consumption of French maritime pine bark extract. Taxifolin was present in serum and synovial fluid exclusively in the intervention group indicating a role as further marker of Pycnogenol® intake. Taxifolin, ferulic acid and caffeic acid were detected in both serum and synovial fluid only in the intervention group. Moreover, the metabolite M1, taxifolin and ferulic acid were only detected simultaneously in all matrices (serum, blood cells and synovial fluid) after ingestion of Pycnogenol®. Thus, deeper insights into the distribution of bioactive constituents and metabolites of Pycnogenol® into serum, blood cells and synovial fluid after oral administration to patients with severe osteoarthritis were gained. The present study provides the first evidence that polyphenols indeed distribute into the synovial fluid of patients with osteoarthritis where they might contribute to clinical effects.},
  subject      = {Pycnogenol},
  language  = {en}
}
@phdthesis{Meyer2015,
  author    = {Meyer, Larissa Valerie},
  title     = {D{\"u}nne Filme, Detektoren sowie Co-Dotierungen und Mischbarkeiten auf Basis von lumineszierenden Erdalkali-/Selten-Erd-Imidazolat-Ger{\"u}stverbindungen},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-121501},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2015},
  abstract  = {This thesis deals with the formation of thin films and luminescence based detectors as well as co-dopings and larger miscibilities in luminescent alkaline earth / rare earth imidazolate coordination polymers and MOFs (metal organic frameworks). The formation of luminescent thin films of the coordination polymers 3∞[Sr1-xEux(Im)2] (x = 0 - 1) and the MOFs 3∞[Tb(Im)3] and 3∞[Ce(Im)3ImH]·ImH on nanostructured alumina substrates (AAO-substrates) was enabled by a new in-situ coating method based on a solvent free melt synthesis. Various layer thicknesses as well as different degrees of coverage were achieved. For the in-situ deposition of 3∞[Sr0.95Eu0.05(Im)2] two different coating strategies for the AAO substrates were established. In addition to the melt approach an electride induced coating method was carried out. Extraordinary baryte rose analogue crystals were observed on the AAO surface for the electride induced coating method. The deposition of the MOFs 3∞[Tb(Im)3] and 3∞[Ce(Im)3ImH]·ImH also took place via CVD processes (chemical vapor deposition). Thin luminescent films of the framework 3∞[Eu(Im)2] on (0001)-sapphire sub-strates were created by a new femto-PLD-process (femto-pulsed-laser-deposition). The films displayed a switchable transparency depending on the wavelength of the incoming light. 3∞[Sr0.95Eu0.05(Im)2], 3∞[Tb(Im)3] and 3∞[Ce(Im)3ImH]·ImH were examined as potential sensors or detectors regarding eight solvents and four gases. The exposure of the networks to water lead to a complete loss of luminescence intensity. MeOH-exposure is followed by a batho-chromic shift of the chromaticity of 3∞[Sr0.95Eu0.05(Im)2] from turquoise to orange. Acetone, pyridine, toluene, hexane, acetonitrile and dichloromethane increase the luminescence in-tensity of 3∞[Sr0.95Eu0.05(Im)2] and 3∞[Tb(Im)3]. The luminescence intensity of 3∞[Ce(Im)3ImH]·ImH is increased by acetonitrile as well as dichloromethane, but decreased under the influence of the other investigated solvents. The interaction of O2 and CO2 lead to a decrease of luminescence intensity by a turn-off-effect with the compounds 3∞[Tb(Im)3] and 3∞[Ce(Im)3ImH]·ImH, whereas no influence on the luminescence intensity of 3∞[Sr0.95Eu0.05(Im)2] was observed during exposure to N2, Ar, O2 and CO2. New coordination polymers 3∞[La4(Im)12(ImH)5]∙xImH (x = 2 - 3) and 3∞[Gd(Im)3] were synthe-sized as missing parts in the field of rare earth imidazolates. Both networks and the known alkaline earth imidazolates 2∞[Ca(Im)2(ImH)2], 3∞[Sr(Im)2] and 3∞[Ba(Im)2] as well as the rare earth imidazolates 3∞[Y(Im)3], 3∞[Ln(Im)3ImH]·ImH (Ln = Ce, Pr, Nd, Sm), 3∞[Gd2(Im)6(ImH)1.5]·0.5 ImH and 3∞[Tb(Im)3] were used as host lattice for the intrinsic luminescence of the Ln-ions Ce3+, Sm3+, Eu2+, Tb3+, Dy3+ and Yb3+. In addition to co-doping, larger miscibilities and possible phase boundaries were investigated. The correlation be-tween structure and luminescence as well as the possibility of color tuning based on additive color mixing of the emission colors were explored with the obtained bulk materials. Furthermore, the solvent free approach was expanded to alkaline earth and lanthanide met-als and the bicyclic ligand 1H-benzimidazole. The monomeric complexes [M(BIm)2(BImH)4] (M = Ca, Sr, Eu) and the two dimensional coordination polymers ²[AE(BIm)2] (AE = Mg, Ba) and ²[Eu(BIm)2(BImH)2] were synthesized and fully characterized. In the case of the Ba con-taining network two polymorphic forms of the network were obtained.},
  subject      = {Metallorganisches Netzwerk},
  language  = {de}
}